After implantation of a continuous-flow left ventricular assist device (CF-LVAD), exercise
capacity in heart failure patients remains reduced with peak oxygen uptake (peak VO 2) …

Pulsatility seems to have a teleological role because evolutionary hierarchy favors higher
ordered animals with more complex, multichamber circulatory systems that generate higher …

BACKGROUND: Pulsatile left ventricular assist devices (LVADs) are effective as bridge-to-
transplant therapy, but they are limited by their large size and lack of durability. Smaller …

Objectives: Using flow-mediated vasodilation (FMD) and reactive hyperemia (RH), this study
aimed to provide greater insight into left ventricular assist device (LVAD)–induced changes …

Background—Left ventricular assist devices (LVADs) are now widely accepted as an option
for patients with advanced heart failure. First-generation devices were pulsatile, but they had …

BACKGROUND: Limited data exist about the long-term effects of continuous-flow vs
pulsatile-flow left ventricular assist devices (LVADs) on end-organ function. METHODS: We …

PURPOSE: Newer continuous-flow left ventricular assist devices (LVAD) have the
advantage of smaller size and increased durability. Questions remain regarding the safety …

Background Patients undergoing heart transplant are at high risk for postoperative
vasoplegia. Despite its frequency and association with poor clinical outcomes, there remains …

BACKGROUND: Continuous-flow left ventricular assist devices (LVADs) such as the
HeartMate II have become the therapy of choice in patients with end-stage heart failure. The …

Left ventricular assist devices (LVADs) are common and implantation carries risk of AKI.
LVADs are used as a bridge to heart transplantation or as destination therapy. Patients with …